ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,468 | -48.2% | 100,400 | -46.2% | 0.33% | -46.8% |
| Q4 2022 | $6,689 | -99.9% | 186,500 | -22.3% | 0.62% | -18.3% |
| Q3 2022 | $8,687,000 | +534.6% | 240,000 | +557.5% | 0.75% | +1408.0% |
| Q2 2022 | $1,369,000 | -78.9% | 36,500 | -77.5% | 0.05% | -94.8% |
| Q3 2021 | $6,476,000 | -81.1% | 161,900 | -79.2% | 0.97% | -81.0% |
| Q2 2021 | $34,236,000 | 0.0% | 778,800 | 0.0% | 5.08% | +6.1% |
| Q1 2021 | $34,236,000 | – | 778,800 | – | 4.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |